Reply to: "Liver fibrosis and adverse outcomes in COVID-19"

Dig Liver Dis. 2021 Jul;53(7):800. doi: 10.1016/j.dld.2021.04.001. Epub 2021 Apr 18.

¹ Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Liver Fibrosis and Nutrition lab (LFN-Lab), Mexico City, Mexico; MICTLÁN Network: mechanisms of liver injury, cell death and translational nutrition in liver diseases-research network.
² Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
³ Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Liver Fibrosis and Nutrition lab (LFN-Lab), Mexico City, Mexico; MICTLÁN Network: mechanisms of liver injury, cell death and translational nutrition in liver diseases-research network. Electronic address: ricardomacro@yahoo.com.mx.

No abstract available

Publication types